Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

ASO Author Reflections: A Reappraisal of Internal Mammary Chain Sentinel Node Biopsy in Breast Cancer Patients: Recommendations for Clinical Practice.

van Loevezijn AA, van der Ploeg IMC.

Ann Surg Oncol. 2019 Jan 23. doi: 10.1245/s10434-019-07194-1. [Epub ahead of print] No abstract available.

PMID:
30675705
2.

Internal Mammary Chain Sentinel Nodes in Early-Stage Breast Cancer Patients: Toward Selective Removal.

van Loevezijn AA, Bartels SAL, van Duijnhoven FH, Heemsbergen WD, Bosma SCJ, Elkhuizen PHM, Donswijk ML, Rutgers EJT, Oldenburg HSA, Vrancken Peeters MTFD, van der Ploeg IMC.

Ann Surg Oncol. 2019 Apr;26(4):945-953. doi: 10.1245/s10434-018-7058-5. Epub 2018 Nov 21.

PMID:
30465222
3.

[Gastrografin as a prognostic and therapeutic medium; use for small bowel obstruction, but not for closed loop obstruction].

van Loevezijn AA, Smithuis RHM, van den Bremer J.

Ned Tijdschr Geneeskd. 2018 May 4;162. pii: D2408. Dutch.

PMID:
30040276
4.

The selective 5-HT6 receptor antagonist SLV has putative cognitive- and social interaction enhancing properties in rodent models of cognitive impairment.

de Bruin NMWJ, van Loevezijn A, Wicke KM, de Haan M, Venhorst J, Lange JHM, de Groote L, van der Neut MAW, Prickaerts J, Andriambeloson E, Foley AG, van Drimmelen M, van der Wetering M, Kruse CG.

Neurobiol Learn Mem. 2016 Sep;133:100-117. doi: 10.1016/j.nlm.2016.06.020. Epub 2016 Jun 21.

PMID:
27344942
5.

Optimization of N'-(arylsulfonyl)pyrazoline-1-carboxamidines by exploiting a novel interaction site in the 5-HT6 antagonistic binding pocket.

van Loevezijn A, Venhorst J, Iwema Bakker WI, Lange JHM, de Looff W, Henzen R, de Vries J, van de Woestijne RP, den Hartog AP, Verhoog S, van der Neut MAW, de Bruin NMWJ, Kruse CG.

Bioorg Med Chem Lett. 2016 Mar 15;26(6):1605-1611. doi: 10.1016/j.bmcl.2016.02.001. Epub 2016 Feb 2.

PMID:
26876931
6.

[Breast-specific gamma imaging in breast cancer].

van Loevezijn AA, van Breda Vriesman AC, Neijenhuis PA, Pereira Arias-Bouda LM.

Ned Tijdschr Geneeskd. 2016;160:A9610. Dutch.

PMID:
26786798
7.

Identification and development of biphenyl substituted iminosugars as improved dual glucosylceramide synthase/neutral glucosylceramidase inhibitors.

Ghisaidoobe AT, van den Berg RJ, Butt SS, Strijland A, Donker-Koopman WE, Scheij S, van den Nieuwendijk AM, Koomen GJ, van Loevezijn A, Leemhuis M, Wennekes T, van der Stelt M, van der Marel GA, van Boeckel CA, Aerts JM, Overkleeft HS.

J Med Chem. 2014 Nov 13;57(21):9096-104. doi: 10.1021/jm501181z. Epub 2014 Oct 17.

PMID:
25250725
8.

Feasibility of measuring physical activity using accelerometry in hospitalized and community-living older people with cognitive impairment.

van Loevezijn AA, Cameron ID, Kurrle SE, van Bodegom D.

J Am Geriatr Soc. 2014 Feb;62(2):388-90. doi: 10.1111/jgs.12662. No abstract available.

PMID:
24521372
9.

A novel highly selective 5-HT6 receptor antagonist attenuates ethanol and nicotine seeking but does not affect inhibitory response control in Wistar rats.

de Bruin NM, McCreary AC, van Loevezijn A, de Vries TJ, Venhorst J, van Drimmelen M, Kruse CG.

Behav Brain Res. 2013 Jan 1;236(1):157-65. doi: 10.1016/j.bbr.2012.08.048. Epub 2012 Sep 4.

PMID:
22974550
10.

N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT₆R) antagonists with unique structural features.

van Loevezijn A, Venhorst J, Iwema Bakker WI, de Korte CG, de Looff W, Verhoog S, van Wees JW, van Hoeve M, van de Woestijne RP, van der Neut MA, Borst AJ, van Dongen MJ, de Bruin NM, Keizer HG, Kruse CG.

J Med Chem. 2011 Oct 27;54(20):7030-54. doi: 10.1021/jm200466r. Epub 2011 Sep 26.

PMID:
21866910
11.

Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.

de Bruin NM, Prickaerts J, van Loevezijn A, Venhorst J, de Groote L, Houba P, Reneerkens O, Akkerman S, Kruse CG.

Neurobiol Learn Mem. 2011 Sep;96(2):392-402. doi: 10.1016/j.nlm.2011.06.015. Epub 2011 Jul 3.

PMID:
21757018
12.

Synthesis of spirohydantoins and spiro-2,5-diketopiperazines via resin-bound cyclic alpha,alpha-disubstituted alpha-amino esters.

Kuster GJ, van Berkom LW, Kalmoua M, van Loevezijn A, Sliedregt LA, van Steen BJ, Kruse CG, Rutjes FP, Scheeren HW.

J Comb Chem. 2006 Jan-Feb;8(1):85-94.

PMID:
16398558
13.

Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.

van der Pol MA, Broxterman HJ, Pater JM, Feller N, van der Maas M, Weijers GW, Scheffer GL, Allen JD, Scheper RJ, van Loevezijn A, Ossenkoppele GJ, Schuurhuis GJ.

Haematologica. 2003 Feb;88(2):134-47.

14.

Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.

Allen JD, van Loevezijn A, Lakhai JM, van der Valk M, van Tellingen O, Reid G, Schellens JH, Koomen GJ, Schinkel AH.

Mol Cancer Ther. 2002 Apr;1(6):417-25.

15.

Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines.

van Loevezijn A, Allen JD, Schinkel AH, Koomen GJ.

Bioorg Med Chem Lett. 2001 Jan 8;11(1):29-32.

PMID:
11140726

Supplemental Content

Loading ...
Support Center